Exploring the efficacy and molecular mechanism of Danhong injection comprehensively in the treatment of idiopathic pulmonary fibrosis by combining meta-analysis, network pharmacology, and molecular docking methods

被引:0
|
作者
Wu, Xiaozheng [1 ]
Li, Wen [1 ]
Luo, Zhenliang [1 ]
Chen, Yunzhi [1 ]
机构
[1] Guizhou Univ Tradit Chinese Med, Dept Preclin Med, Guiyang 510025, Peoples R China
关键词
Danhong; idiopathic pulmonary fibrosis; meta-analysis; network pharmacology; MESENCHYMAL TRANSITION; KAEMPFEROL; PATHWAYS; LUTEOLIN; RECEPTOR; CELLS; PATHOGENESIS; EXPRESSION; LANDSCAPE; THERAPY;
D O I
10.1097/MD.0000000000038133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Danhong injection, a compound injection of Chinese herbal medicine, has been widely used in idiopathic pulmonary fibrosis (IPF) at present as an adjuvant treatment. However, the clinical efficacy and molecular mechanism of IPF are still unclear. This study will evaluate and explore the clinical efficacy and molecular mechanism of Danhong injection in the treatment of IPF. Methods: In meta-analysis, the computer was used to search 8 databases (PubMed, EMbase, CENTRAL, MEDLINE, CBM, CNKI, WanFang, and VIP) to collect the RCTs, and RevMan 5.3 and Stata 14.0 were used for statistical analysis. It has been registered on PROSPERO: CRD42020221096. In network pharmacology, the main chemical components and targets of the chemical components of Danhong injection were obtained in TCMSP and Swiss Target Prediction databases. The main targets of IPF were obtained through Gencards, Disgenet, OMIM, TTD, and DRUGBANK databases. The String platform was used to construct PPI networks. Cytoscape 3.8.2 was used to construct the "Danhong components - IPF targets-pathways" network. The molecular docking verification was conducted by Auto Dock. Results: Twelve RCTs were finally included with a total of 896 patients. The meta-analysis showed that Danhong injection could improve the clinical efficiency ([OR] = 0.25, 95% CI [0.15, 0.41]), lung function, arterial blood gas analysis, inflammatory cytokines, and serum cytokines associated with pulmonary fibrosis of IPF patients, respectively (P < .05). The core active components of Danhong injection on IPF were Luteolin, Quercetin, and Kaempferol, and the core targets were PTGS2, AR, ESR1, PPARG, and RELA. Danhong injection mainly improved IPF through PD-L1 expression and PD-1 checkpoint path in cancer, pathways in cancer, PI3K-Akt signaling pathway, etc. Conclusion: These results provided scientific basis for the clinical use of Danhong injection for the treatment of IPF, and provided a new direction to explore the potential mechanism of action of Danhong injection.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Mechanism of Danhong Injection in the Treatment of Arrhythmia Based on Network Pharmacology, Molecular Docking, and In Vitro Experiments
    Yu, Tingting
    Li, Yuxin
    Yan, Meihui
    Zhang, Zhang
    Yuan, Xin
    Li, Sen
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [2] Danhong injection in the treatment of idiopathic pulmonary fibrosis A protocol for systematic review and meta-analysis
    Lan, Yanqiu
    Wu, Dezhi
    Jin, Yunrui
    Shui, Min
    Fan, Xianjun
    MEDICINE, 2020, 99 (37) : E22016
  • [3] The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis A network pharmacology and molecular docking study
    Wu, Xiaozheng
    Li, Wen
    Luo, Zhenliang
    Chen, Yunzhi
    MEDICINE, 2022, 101 (06)
  • [4] Molecular Mechanism of Qingzaojiufei Decoction in the Treatment of Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking
    Zhao, Yilong
    Liu, Bohao
    Li, Yixing
    Chen, Zhe
    Zhu, Xingzhuo
    Tao, Runyi
    Wang, Zhiyu
    Wang, Hongyi
    Zhang, Yanpeng
    Yan, Shuguang
    Gong, Qiuyu
    Zhang, Guangjian
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (27) : 2161 - 2176
  • [5] Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking
    Chen, Haixu
    Lin, Yu
    Zeng, Lianlin
    Liu, Shiwei
    MEDICINE, 2022, 101 (51)
  • [6] Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
    Bram Rochwerg
    Binod Neupane
    Yuan Zhang
    Carlos Cuello Garcia
    Ganesh Raghu
    Luca Richeldi
    Jan Brozek
    Joseph Beyene
    Holger Schünemann
    BMC Medicine, 14
  • [7] Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
    Rochwerg, Bram
    Neupane, Binod
    Zhang, Yuan
    Garcia, Carlos Cuello
    Raghu, Ganesh
    Richeldi, Luca
    Brozek, Jan
    Beyene, Joseph
    Schuenemann, Holger
    BMC MEDICINE, 2016, 14
  • [8] Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation
    Velazquez-Enriquez, Juan Manuel
    Santos-Alvarez, Jovito Cesar
    Ramirez-Hernandez, Alma Aurora
    Reyes-Jimenez, Edilburga
    Mayoral, Laura Perez-Campos
    Romero-Tlalolini, Maria de los Angeles
    Jimenez-Martinez, Cristian
    Arellanes-Robledo, Jaime
    Villa-Trevino, Saul
    Vasquez-Garzon, Veronica Rocio
    Baltierrez-Hoyos, Rafael
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 734
  • [9] Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
    Hou, Yuan
    Wang, Guoyu
    Han, Shuo
    Liu, Huaman
    Jia, Xinhua
    MEDICINE, 2023, 102 (22) : E33729
  • [10] Network pharmacology and molecular docking analysis on the mechanism of Wensan tincture in the treatment of pulmonary nodules: A review
    Zhang, Jinzhi
    Yang, Jingqi
    Li, Guangxi
    MEDICINE, 2024, 103 (48)